Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Allan

Showing results (261-270 of 315) with videos related to

Pageof 32
Sort By:
Thorax|February 5, 2017
Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosisAlexander Edwards, Yifang Gao, Raymond N Allan, et al.
Pharmaceutics|March 28, 2026
Synthesis and Characterisation of Bioactive Fluorescent FITC-Insulin Glulisine Conjugates for Potential Use in Insulin DeliveryUnmesh J Desai, M Joan Taylor, Sangeeta Tanna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2023
Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus VenetoclaxNitin Jain, Lisa J Croner, John N Allan, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2019
Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosaOdel Soren, Ardeshir Rineh, Diogo G Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2022
Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration CohortsPaul M Barr, Alessandra Tedeschi, William G Wierda, et al.
Arquivos De Neuro-Psiquiatria|December 6, 2000
Huntington disease: DNA analysis in Brazilian populationS Raskin, N Allan, H A Teive, et al.
Haematologica|January 19, 2023
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergyFrancesca Arruga, Marta Rubin, Despoina Papazoglou, et al.
Nitric Oxide : Biology and Chemistry|February 26, 2017
Cephalosporin-NO-donor prodrug PYRRO-C3D shows β-lactam-mediated activity against Streptococcus pneumoniae biofilmsRaymond N Allan, Michael J Kelso, Ardeshir Rineh, et al.
Cell Genomics|October 11, 2025
Co-mapping clonal and transcriptional heterogeneity in somatic evolution via GoT-MultiMinwoo Pak, Mirca S Saurty-Seerunghen, Kellie Wise, et al.
Haematologica|March 18, 2021
Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemiaKerry A Rogers, Philip A Thompson, John N Allan, et al.
Pageof 32

Showing results (261-270 of 315) with videos related to

Sort By:
Pageof 32
Thorax|February 5, 2017
Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosisAlexander Edwards, Yifang Gao, Raymond N Allan, et al.
Pharmaceutics|March 28, 2026
Synthesis and Characterisation of Bioactive Fluorescent FITC-Insulin Glulisine Conjugates for Potential Use in Insulin DeliveryUnmesh J Desai, M Joan Taylor, Sangeeta Tanna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2023
Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus VenetoclaxNitin Jain, Lisa J Croner, John N Allan, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2019
Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosaOdel Soren, Ardeshir Rineh, Diogo G Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2022
Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration CohortsPaul M Barr, Alessandra Tedeschi, William G Wierda, et al.
Arquivos De Neuro-Psiquiatria|December 6, 2000
Huntington disease: DNA analysis in Brazilian populationS Raskin, N Allan, H A Teive, et al.
Haematologica|January 19, 2023
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergyFrancesca Arruga, Marta Rubin, Despoina Papazoglou, et al.
Nitric Oxide : Biology and Chemistry|February 26, 2017
Cephalosporin-NO-donor prodrug PYRRO-C3D shows β-lactam-mediated activity against Streptococcus pneumoniae biofilmsRaymond N Allan, Michael J Kelso, Ardeshir Rineh, et al.
Cell Genomics|October 11, 2025
Co-mapping clonal and transcriptional heterogeneity in somatic evolution via GoT-MultiMinwoo Pak, Mirca S Saurty-Seerunghen, Kellie Wise, et al.
Haematologica|March 18, 2021
Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemiaKerry A Rogers, Philip A Thompson, John N Allan, et al.
Pageof 32